-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The first batch of Covey's new coronavirus inactivated vaccines independently developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (hereinafter referred to as the Institute of Biology of the Chinese Academy of Medical Sciences) was launched for domestic emergency use, adding another weapon to China's fight against the new crown epidemic.
It is reported that since the outbreak of the new coronavirus pneumonia, under the overall deployment of the Party Central Committee and the State Council, the Institute of Biology of the Academy of Medical Sciences has actively undertaken scientific research tasks for epidemic prevention and control, and carried out research on emergency vaccine research and development, animal model establishment, virus traceability and transmission mechanism.
At present, the industrialization of the vaccine is steadily advancing, and the newly-built new crown inactivated vaccine production workshop in the Majinpu Vaccine Industrial Base of the Institute of Biology of the Academy of Medical Sciences has been officially put into use
The immunization program of the new crown inactivated vaccine developed by the Institute of Biology of the Medical Academy is the same as that of similar vaccines.